Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity

Neuroendocrinology
D R Packan, R M Sapolsky

Abstract

Glucocorticoids (GCs) can damage the hippocampus when exposure is prolonged, as well as impair the capacity of hippocampal neurons to survive various neurological insults. We have recently demonstrated that GCs impair the capacity of primary hippocampal cultures to survive many of these same insults. Using this culture system, we have characterized the features with which the GC corticosterone (CORT) impairs the capacity of these cells to survive the excitotoxin kainic acid. The GC endangerment seems to be mediated by the type II, but not type I corticosteroid receptor. As evidence for type II involvement, endangerment of cells was caused by CORT concentrations in the kilodalton range for the type II receptor, and also by the type II ligand dexamethasone; moreover, the endangerment was blocked by a type II antagonist. In contrast, a type I antagonist was not protective. Cultures contained both type I and II receptors. The effect was GC-specific, as cultures were endangered by CORT, cortisol and dexamethasone, but not by non-GC steroids. GCs did not exacerbate kainic acid damage in cerebeller or hypothalamic cultures, despite the presence of corticosteroid receptors. This agrees with the in vivo data showing that the GC exacerba...Continue Reading

Citations

May 10, 2002·Depression and Anxiety·Eric Vermetten, J Douglas Bremner
Jul 1, 1994·Developmental Psychobiology·A S ClarkeM L Schneider
Jan 15, 1999·Molecular Neurobiology·M Joëls, E Vreugdenhil
Jul 5, 2003·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·C ZhuP Yan
Mar 29, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Peter Heiduschka, Solon Thanos
May 1, 1995·Journal of Neuroscience Methods·R SapolskyB Stein-Behrens
Nov 30, 1993·Behavioural Brain Research·R M Sapolsky
May 1, 1993·Brain Research. Molecular Brain Research·J R SecklG Fink
Jul 5, 1996·Neuroscience Letters·C A SingerD M Dorsa
Jun 1, 1994·Toxicology in Vitro : an International Journal Published in Association with BIBRA·F D Hayes, K C Breen
May 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·J L Scully, U Otten
Apr 15, 2003·Brain Research·Ralphiel S PayneAvital Schurr
Jun 1, 1997·Brain Research. Brain Research Reviews·S J Lupien, B S McEwen
Jun 26, 2003·Brain Research. Molecular Brain Research·Paul R LeeJames I Koenig
Aug 7, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·R Nass, M O Thorner
Aug 8, 2001·Journal of Neuroendocrinology·M Joëls
Jul 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·V L Smith-SwintoskyM P Mattson
Apr 16, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H J KrugersS Knollema
Oct 26, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H J KrugersM Joëls
Jun 23, 2000·Journal of Pediatric Hematology/oncology·D P WaberS E Sallan
Aug 17, 2006·The Australian and New Zealand Journal of Psychiatry·Lisa J PhillipsGregor Berger
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·A M MagariñosB S McEwen
Dec 1, 1992·Neurochemical Research·A CestelliI Di Liegro
Sep 1, 1992·Journal of Neurochemistry·E M Elliott, R M Sapolsky
Apr 1, 1992·Journal of Neurochemistry·M T Lowy
Mar 13, 2014·Journal of Molecular Neuroscience : MN·Kimberly R LezakSayamwong E Hammack
Jun 16, 2009·Canadian Journal of Physiology and Pharmacology·Jung-Man YouEunjoo H Lee
Jun 6, 2009·Harvard Review of Psychiatry·Daniel J Zimmerman, Lois Wonsun Choi-Kain
Jul 2, 2005·Journal of Psychiatric Practice·C CorcoranD Malaspina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.